Close

What is pulmonary hypertension?

Pulmonary HTN

Pulmonary hypertension (PH) is a serious medical condition characterized by elevated blood pressure in the arteries that supply the lungs (pulmonary arteries). This condition occurs when the pulmonary arteries become narrowed, blocked or damaged, making it difficult for blood to flow freely. As a result, the heart works harder to pump blood through the lungs, which can lead to the right side of the heart becoming enlarged and weakened. 

PH is a progressive disease that can lead to heart failure if left untreated. The symptoms are often vague and can mimic other respiratory or cardiovascular conditions, making diagnosis challenging.

Types of pulmonary hypertension

PH is classified into five groups based on its underlying cause. These include:

Group 1: Pulmonary arterial hypertension (PAH)
This type involves the narrowing and stiffening of the small arteries in the lungs. It can be idiopathic (with no known cause) or caused by genetic mutations, certain medications, connective tissue diseases (like scleroderma or lupus) or HIV/AIDS.

Group 2: PH due to left heart disease
This is the most common type and occurs when left-sided heart diseases, such as heart failure or valvular disease, cause increased pressure in the pulmonary venous system.

Group 3: PH due to lung disease and/or hypoxia
Chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), interstitial lung disease or sleep apnea can lead to PH due to low oxygen levels in the blood.

Group 4: Chronic thromboembolic pulmonary hypertension (CTEPH)
This type is caused by blood clots that block or damage the pulmonary arteries, leading to increased pressure in the lungs.

Group 5: PH with unclear multifactorial mechanisms
This group includes cases of PH where the cause is unclear or involves multiple contributing factors, such as certain metabolic or hematological disorders.

Symptoms of pulmonary hypertension

The symptoms of PH can develop slowly and may not be noticeable in the early stages. However, as the condition progresses, the following signs may appear:

  • Shortness of breath (especially with physical activity)
  • Fatigue or weakness
  • Chest pain or discomfort
  • Swelling in the ankles, legs or abdomen (edema)
  • Dizziness or fainting (syncope)
  • Bluish tint to lips or skin (cyanosis) due to low oxygen levels
  • Heart palpitations or irregular heartbeats (arrhythmia)

If left untreated, PH can lead to severe complications, including right-sided heart failure, which is the inability of the right side of the heart to pump blood efficiently.

Causes and risk factors

The exact cause of pulmonary hypertension varies depending on the type of PH. In general, some factors that increase the risk of developing PH include:

  • Family history: Genetic mutations can increase the risk of developing PAH, especially in cases of idiopathic pulmonary hypertension (IPAH).
  • Chronic lung disease: Conditions like COPD, interstitial lung disease and sleep apnea can damage the pulmonary vessels and contribute to PH.
  • Heart conditions: Diseases such as heart failure or congenital heart defects can lead to PH.
  • Blood clots: Previous blood clots in the lungs (pulmonary embolism) can cause CTEPH.
  • HIV/AIDS: HIV infection can contribute to the development of pulmonary hypertension due to the virus itself or associated treatments.
  • Medications: Certain drugs, such as the appetite suppressant Aminorex, methamphetamine, dasatinib and toxic rapeseed oil, may increase the risk of PH.
Graphic - Pulmonary HTN
Diagnosis of pulmonary hypertension

Diagnosing PH requires a combination of clinical evaluation, medical history and a variety of diagnostic tests. Some of the key diagnostic tools include:

  • Echocardiogram: A non-invasive ultrasound of the heart that can estimate the pressure in the pulmonary arteries.
  • Right heart catheterization: This is the gold standard test for diagnosing PH. It involves threading a catheter through a vein to measure the pressures within the pulmonary arteries directly.
  • Electrocardiogram (ECG): This test can detect heart rhythm abnormalities that may indicate PH.
  • Chest X-ray or CT scan: Imaging tests that can reveal signs of heart enlargement or lung disease.
  • Pulmonary function tests: These tests assess how well the lungs are functioning, helping to identify lung diseases that may contribute to PH.
Treatment options for pulmonary hypertension

While there is no cure for PH, various treatments can help manage the condition and improve quality of life. The goal of treatment is to reduce the symptoms, improve exercise tolerance and prevent complications.

Medications:

  • Endothelin receptor antagonists (ERAs): These drugs block endothelin, a substance that constricts blood vessels.
  • Phosphodiesterase type 5 inhibitors (PDE5 inhibitors): These medications relax the blood vessels in the lungs, improving blood flow.
  • Prostacyclin analogs: These medications help dilate the pulmonary arteries and improve blood flow.
  • Soluble guanylate cyclase stimulators: These drugs help relax the pulmonary arteries and reduce pressure.
  • Soteracept: An activin signaling inhibitor that works against the vascular remodeling that occurs during pulmonary hypertension.
  • Diuretics: Used to reduce fluid buildup and swelling.
  • Anticoagulants: Blood thinners may be prescribed in cases of CTEPH to prevent blood clots.

Oxygen therapy:

  • Supplemental oxygen may be prescribed for patients who have low blood oxygen levels.

Lifestyle changes:

  • Patients with PH are advised to avoid excessive physical activity, stop smoking and maintain a healthy diet.
  • In severe cases, a lung transplant may be necessary for patients who fail to respond to other treatments.

Surgical procedures:

  • In cases of CTEPH, surgery to remove the blood clots (pulmonary endarterectomy) may be performed.
Prognosis and living with pulmonary hypertension

Pulmonary hypertension is a chronic condition that requires ongoing management. The prognosis depends on the underlying cause, the stage of the disease at diagnosis and the effectiveness of treatment. With early diagnosis and appropriate treatment, many individuals with PH can lead active lives. However, PH is a serious condition, and without treatment, it can lead to heart failure and reduced life expectancy.

Patients with pulmonary hypertension are encouraged to work closely with a health care team, including cardiologists, pulmonologists and specialists in PH, to develop a comprehensive treatment plan. Regular follow-up appointments and monitoring are essential for adjusting treatment and managing symptoms.

Conclusion

Pulmonary hypertension is a complex and potentially life-threatening condition that affects the lungs and the heart. Early detection, accurate diagnosis and appropriate treatment are crucial for managing the disease and improving the quality of life for those affected. With advancements in medical therapies, many individuals with pulmonary hypertension can manage their symptoms and live more comfortably.


Learn more about pulmonary hypertension at Northside.

 

Media Inquiries

Northside Hospital's media relations staff look forward to assisting you with news stories whenever possible. We promise to try and meet all of your story needs.
Media Contacts


Featured Provider

Dr. Paul D. Boyce picture

Dr. Paul D. Boyce

Specialties: Pulmonary and Critical Care

View Profile

Dr. Paul D. Boyce has served as the Pulmonary Section Chief and Respiratory Care Director of the Northside Hospital System. His diverse clinical interests encompass various pulmonary health issues, particularly pulmonary hypertension, pulmonary emboli, sarcoidosis, asthma and occupational lung diseases.

Need Help Finding a Provider?
Take advantage of Northside Hospital's free physician referral service. Available weekdays , 8a.m. - 4p.m. EST. 404-845-5555